Predictive Oncology Inc.
POAI | NASDAQ
$4.91
$0.00 (0.00%)
Nov 2, 2026, 9:33 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.45 | -5.49 | -14.18 | -13.19 | -39.89 | -4.96 |
PEG Ratio | 0 | 0.15 | 0.28 | 5.25 | 0.48 | 0.07 |
PS Ratio | 827.78 | 41.31 | 121.73 | 225.50 | 548.85 | 102.58 |
PB Ratio | 2.17 | -331.08 | 23.95 | 15.60 | 19.36 | 48.61 |
P/FCF Ratio | -10.41 | -5.61 | -15 | -26.43 | -59.20 | -10.18 |
P/OCF Ratio | -10.41 | -5.61 | -15.02 | -27.44 | -63.87 | -10.48 |
OCF/S Ratio | -7.95K | -736.27 | -810.31 | -821.73 | -859.37 | -978.84 |
Debt / Equity Ratio | 0.03 | -10.52 | 0.33 | 0.01 | 0.02 | 2.22 |
Quick Ratio | 4.30 | 0.51 | 2.43 | 5.91 | 8.97 | 0.13 |
Current Ratio | 10.02 | 0.62 | 2.55 | 6.02 | 9.09 | 0.16 |
Asset Turnover | 0 | 0.33 | 0.11 | 0.06 | 0.03 | 0.10 |
Interest Coverage | n/a | n/a | n/a | -2.44 | n/a | n/a |
Return on Equity | -488.50% | 6.02K% | -169.06% | -118.25% | -48.82% | -979.47% |
Return on Assets | -440.73% | -245.37% | -96.99% | -100.01% | -44.91% | -198.19% |
Return on Invested Capital | -57.56% | -560.47% | -109.55% | -118.62% | -48% | -289.73% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 42.03% | 49.12% | 62.57% | 66.45% | 65.72% | 64.29% |
Net Profit Margin | -186.05K% | -751.39% | -859.13% | -1.71K% | -1.38K% | -2.07K% |
Pretax Profit Margin | -185.86K% | -668.81% | -738.32% | -1.71K% | -1.43K% | -2.07K% |
Operating Profit Margin | -22.69K% | -673.69% | -744.47% | -1.73K% | -1.44K% | -2.03K% |
FCF Margin | -7.95K% | -736.86% | -811.63% | -853.33% | -927.11% | -1.01K% |
EBITDA Margin | -185.31K% | -625.97% | -723.28% | -926.94% | -853.91% | -915.03% |
Add to Watchlist
Select watchlists to add or remove POAI